MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales : vima

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) reported that preliminary Monjuvi U.S. net product sales were $23.6 million for the fourth quarter and $79.1 million for the full year 2021.

Related Keywords

Martinsried , Bayern , Germany , Jean Paul Kress , , Chief Executive Officer , Morphosys , Reports , Reliminary , 021 , Monjuvi , Sales ,